SCHEMBL17482121

SCHEMBL17482121

CC(C)COC(=O)/C=C/c1ccccc1O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.54
LMNA P02545 1/20 0.54
NFKB1 P19838 2/20 0.53
JUN P05412 1/20 0.53
NFE2L2 Q16236 1/20 0.53
CA1 P00915 1/20 0.51
CA2 P00918 1/20 0.51
CA4 P22748 1/20 0.51
ALOX5 P09917 2/20 0.49
MAPK1 P28482 2/20 0.49
KDM4E B2RXH2 1/20 0.49
NPC1 O15118 1/20 0.49
RAB9A P51151 1/20 0.49
ATM Q13315 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
BCHE P06276 1/20 0.47
GUSB P08236 1/20 0.47
ALDH1A1 P00352 2/20 0.46
TSHR P16473 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9744921 0.86 AKR1B10 (0.46) MAPTLMNANFKB1JUNNFE2L2
SCHEMBL28658531 0.85 ALDH1A1 (0.47) MAPTLMNAALOX5KDM4ERAB9A
SCHEMBL28658533 0.85 ALDH1A1 (0.47) MAPTLMNAALOX5KDM4ERAB9A
SCHEMBL2391128 0.83 MAPT (0.59) MAPTLMNANFKB1JUNNFE2L2
SCHEMBL3132306 0.83 MAPT (0.59) MAPTLMNANFKB1JUNNFE2L2
SCHEMBL20475031 0.82 NFE2L2 (0.61) MAPTLMNANFE2L2MAPK1KDM4E
SCHEMBL19901101 0.81 NFKB1 (0.59) MAPTLMNANFKB1JUNNFE2L2
SCHEMBL28650877 0.80 ALDH1A1 (0.42) MAPTLMNAALOX5MAPK1KDM4E
SCHEMBL28650880 0.80 ALDH1A1 (0.42) MAPTLMNAALOX5MAPK1KDM4E
SCHEMBL11823522 0.80 APP (0.58) MAPTLMNANFKB1JUNNFE2L2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160032376-A1 NUCLEOTIDE ANALOGS FOR SEQUENCING IBIS BIOSCIENCES, INC. 2016-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160032376-A1 NUCLEOTIDE ANALOGS FOR SEQUENCING RNGTT, POLRMT, NT5C3B MAPT 3797/4885LMNA 988/4885NFKB1 4176/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.